Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Brand-Schieber, Elimor
37  Ergebnisse:
Personensuche X
?
1

Efficacy of ubrogepant for the treatment of migraine sympto..:

Goadsby, Peter ; Ailani, Jessica ; Dodick, David...
Journal of the Neurological Sciences.  455 (2023)  - p. 121630 , 2023
Link: https://doi.org/10.1016/..
 
?
2

Efficacy of Ubrogepant for the Treatment of Migraine Sympto..:

Goadsby, Peter J. ; Ailani, Jessica ; Dodick, David W....
Neurology.  100 (2023)  17_supplement_2 - p. , 2023
Link: https://doi.org/10.1212/..
 
?
3

DFN-02, Sumatriptan 10 mg Nasal Spray with Permeation Enhan..:

Lipton, Richard B. ; Munjal, Sagar ; Brand-Schieber, Elimor.
CNS Drugs.  33 (2019)  4 - p. 375-382 , 2019
Link: https://doi.org/10.1007/..
 
?
4

Randomized, Double-Blind, Pilot Study Comparing 3 Mg Subcut..:

Cady, Roger ; Munjal, Sagar ; Cady, Ryan..
Neurology.  92 (2019)  15_supplement - p. , 2019
Link: https://doi.org/10.1212/..
 
?
5

Subjects with Episodic Migraine Treated with DFN-02 (Sumatr..:

Brand-Schieber, Elimor ; Munjal, Sagar
Neurology.  90 (2018)  15_supplement - p. , 2018
Link: https://doi.org/10.1212/..
 
?
6

Efficacy and safety of DFN-11 (sumatriptan injection, 3 mg)..:

Landy, Stephen ; Munjal, Sagar ; Brand-Schieber, Elimor.
The Journal of Headache and Pain.  19 (2018)  1 - p. , 2018
Link: https://doi.org/10.1186/..
 
?
7

Efficacy and safety of DFN-11 (sumatriptan injection, 3 mg)..:

Landy, Stephen ; Munjal, Sagar ; Brand-Schieber, Elimor.
The Journal of Headache and Pain.  19 (2018)  1 - p. , 2018
Link: https://doi.org/10.1186/..
 
?
8

A Randomized, Double-Blind, Placebo-Controlled, Study Evalu..:

Munjal, Sagar ; Brand-Schieber, Elimor
Neurology.  90 (2018)  15_supplement - p. , 2018
Link: https://doi.org/10.1212/..
 
?
9

A multicenter, open-label, long-term safety and tolerabilit..:

Munjal, Sagar ; Brand-Schieber, Elimor ; Allenby, Kent...
The Journal of Headache and Pain.  18 (2017)  1 - p. , 2017
Link: https://doi.org/10.1186/..
 
?
10

Subcutaneous sumatriptan delivery devices: comparative ease..:

Andre, Anthony D ; Brand-Schieber, Elimor ; Ramirez, Margarita..
Patient Preference and Adherence.  11 (2017)  - p. 121-129 , 2017
Link: https://doi.org/10.2147/..
 
?
11

Randomized, double-blind, crossover study comparing DFN-11 ..:

Cady, Roger K. ; Munjal, Sagar ; Cady, Ryan J...
The Journal of Headache and Pain.  18 (2017)  1 - p. , 2017
Link: https://doi.org/10.1186/..
 
?
12

Human factors validation study of 3 mg sumatriptan autoinje..:

Andre, Anthony ; Brand-Schieber, Elimor ; Munjal, Sagar...
Medical Devices: Evidence and Research.  , 2016
Link: https://doi.org/10.2147/..
 
?
13

Effect of renal impairment on the pharmacokinetics of levom..:

Chen, Laishun ; Greenberg, William ; Brand-Schieber, Elimor...
Drug Design, Development and Therapy.  , 2015
Link: https://doi.org/10.2147/..
 
?
14

Safety and tolerability of donepezil 23 mg in moderate to s..:

Farlow, Martin ; Veloso, Felix ; Moline, Margaret...
BMC Neurology.  11 (2011)  1 - p. , 2011
Link: https://doi.org/10.1186/..
 
?
15

Effectiveness and tolerability of high-dose (23 mg/d) versu..:

Farlow, Martin R. ; Salloway, Stephen ; Tariot, Pierre N....
Clinical Therapeutics.  32 (2010)  7 - p. 1234-1251 , 2010
Link: https://doi.org/10.1016/..
 
1-15